Evonik Industries
XTRA:EVK Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 29 Fair Values set on narratives written by author
WA
Consensus Narrative from 15 Analysts
Specialty Chemicals Firm Will Cut Costs And Focus On Biosolutions And Energy Transition For Future Profitability
Key Takeaways Strategic realignment and cost-saving initiatives are expected to enhance focus on high-growth areas, reducing costs and improving net margins. Innovation in Biosolutions, circular economy, and energy transition will drive revenue growth, supported by strong market share gains in key segments.
View narrative€21.35
FV
12.3% undervalued intrinsic discount2.19%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
23 days ago author updated this narrative